Cited by 56Mindfulness and Compassion InterventionsInflammatory Bowel DiseaseCancer survivorship and care

Randomized controlled trial of cognitive-behavioral and mindfulness-based stress reduction on the quality of life of patients with Crohn disease

Goren, Ganit, Schwartz, Doron, Friger, Michael, Banai, Hagar, Sergienko, Ruslan, Regev, Shirley, Abu-Kaf, Heba, Greenberg, Dan +11 more·2022·Inflammatory Bowel Diseases

Abstract

BACKGROUND: Patients with Crohn disease have debilitating psychological symptoms, mental fatigue, and poor quality of life. Psychological intervention may improve these symptoms. METHODS: We performed a randomized parallel-group physician-blinded trial of cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX) on quality of life and psychological symptoms in adults with mild-moderate Crohn disease. COBMINDEX was taught by social workers in one-on-one video conferences over 3 months; quotidian home practice was mandated. RESULTS: Fifty-five COBMINDEX and 61 waitlist control patients completed the study; mean age was 33 years and 65% of participants were women. At 3 months, COBMINDEX patients had significantly reduced disease activity (per Harvey-Bradshaw Index score, C-reactive protein level, and calprotectin level), increased quality of life (Short Inflammatory Bowel Disease Questionnaire [SIBDQ] score increased from baseline 41 to 50; P < 0.001), decreased psychological symptoms (Global Severity Index [GSI], 0.98-0.70; P < 0.001), reduced fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue, 26-33; P < 0.001), and increased mindfulness disposition (Freiburg Mindfulness Inventory, 33-38; P < 0.001). Waitlist patients had a significant but small change in Harvey-Bradshaw Index, SIBDQ, and GSI scores, without improvement in fatigue or mindfulness. There were significant correlations (0.02 > P < 0.002) in COBMINDEX patients between baseline SIBDQ, GSI, Freiburg Mindfulness Inventory, and Functional Assessment of Chronic Illness Therapy-Fatigue scores with a relative change (baseline to 3 months) of the SIBDQ score, but none among waitlist patients. Predictors of relative change of the SIBDQ score in COBMINDEX patients included the GSI score (90% quantile; coefficient 0.52; P < 0.001), somatization (90%; 0.20; P = 0.001), depression (75%; 0.16; P = 0.03), and phobic anxiety (75%; 0.31; P = 0.008). CONCLUSIONS: COBMINDEX was effective in increasing patients' quality of life and reducing psychological symptoms and fatigue. Patients with severe baseline psychological symptoms benefited the most from COBMINDEX.

Integrity signals

Registry

Crossref · 10.1093/ibd/izab083

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goren, G., Schwartz, D., Friger, M., Banai, H., Sergienko, R., Regev, S., Abu-Kaf, H., Greenberg, D., Nemirovsky, A., Ilan, K., Lerner, L., Monsonego, A., Dotan, I., Yanai, H., Eliakim, R., Ben Horin, S., Slonim-Nevo, V., Odes, S., & Sarid, O.
Affiliations
  • Ben-Gurion University of the Negev (IL)
  • Tel Aviv University (IL)
  • Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel
  • Spitzer Department of Social Work, Ben-Gurion University of the Negev , Beer Sheva , Israel
Corresponding author
Odes, Shmuel
Venue
Inflammatory Bowel Diseases
Published
2021-04-13
Volume
28
Issue
3
Pages
393-408
ISSN
  • 1078-0998 (ISSN-L)
  • 1536-4844
OpenAlex
W3156615571
Cited by
56
References
46
Citations by year
2026: 7 · 2025: 17 · 2024: 15 · 2023: 6 · 2022: 8 · 2021: 3
FWCI
5.45
Type
journal article
Language
en
Open access
closed
Locations
  • Inflammatory Bowel Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
Leona M. and Harry B. Helmsley Charitable Trust
Topics
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
Crohn's disease, cognitive behavioral therapy
MeSH terms
Adult, Cognition, Crohn Disease, Depression, Female, Humans, Quality of Life, Stress, Psychological, Mindfulness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review